seizure tracking
The company's REMI product is currently FDA cleared for in-hospital use, but Epitel plans to expand into ambulatory and in-home care.
At Boston Children's Hospital's second annual Innovator's Showcase this week, researchers and clinicians presented a number of new technology-focused offerings that are currently in use or being tested at the hospital.